Consolidated company 01.01-31.12. | IFRS | IFRS | IFRS | IFRS | IFRS |
|---|
| 2009 | 2008 | 2007 | 2006 | 2005 |
| 1 000 | 12 months | 12 months | 12 months | 12 months | 12 months |
Business development | | | | | |
Revenue | 5 628 | 5 127 | 7 895 | 1 118 | 1 227 |
Personnel on average | 81 | 42 | 36 | 37 | 47 |
Personnel at the end of the period | 82 | 80 | 37 | 35 | 45 |
Research and development costs | 21 109 | 8 730 | 9 053 | 7 970 | 7 149 |
Capital expenditure | 475 | 116 | 287 | 819 | 9 |
| | | | | |
Profitability | | | | | |
Operating profit (loss) | -17 631 | -5 121 | -1 769 | -8 361 | -7 381 |
as percentage of revenue, % | -313.27 | -99.90 | -22.4 | -747.6 | -601.3 |
Profit (loss) before taxes | -17 942 | -5 553 | -1 726 | -8 958 | -7 941 |
as percentage of revenue, % | -318.80 | -108.30 | -21.9 | -800.9 | -647.0 |
| | | | | |
Balance sheet | | | | | |
Cash and cash equivalent | 19 744 | 25 238 | 28 243 | 31 763 | 7 082 |
Shareholders´ equity | -8 938 | 110 | -11 117 | -10 807 | -19 583 |
Balance sheet total | 31 526 | 42 804 | 30 075 | 33 233 | 8 930 |
| | | | | |
Financial ratios | | | | | |
Return on equity, % | - | - | - | - | - |
Return on capital employed, % | -86.0 | -18.3 | -7.2 | -113.5 | -426.7 |
Equity ratio, % | -28.4 | 0.3 | -37.0 | -46.5 | -219.3 |
Gearing, % | -67.9 | -148.5 | 40.8 | 76.1 | -72.7 |
| | | | | |
Per share data | | | | | |
Earning per share (EPS,) | -0.11 | -0.06 | -0.02 | -0.16 | -0.17 |
Shareholders´ equity per share, | -0.0563 | 0.0008 | -0.12 | -0.12 | -0.37 |
Dividend per share, | - | - | - | - | - |
Payout ratio, % | - | - | - | - | - |
Effecting dividend yield, % | - | - | - | - | - |
P/E ratio | - | - | - | - | - |
| | | | | |
Share price, | | | | | |
- Lowest share price | 0.23 | 0.24 | 0.75 | 0.49 | 0.49 |
- Highest share price | 0.67 | 0.94 | 1.22 | 2.39 | 1.06 |
- Average share price | 0.42 | 0.51 | 0.98 | 1.10 | 0.75 |
- 31.12. share price | 0.55 | 0.26 | 0.76 | 1.18 | 0.53 |
Market capitalization, Meur | 87.3 | 37.5 | 68.6 | 105.6 | 27.9 |
| | | | | |
Trade of shares | | | | | |
Number of shares traded | 51 471 584 | 15 350 613 | 35 093 743 | 32 470 230 | 9 003 598 |
as percentage of all shares, % | 32.4 | 10.6 | 38.9 | 36.3 | 17.1 |
Adjusted weighted average number of shares during the period | 144 992 735 | 96 734 553 | 90 003 192 | 54 995 830 | 48 689 328 |
Adjusted weighted number of shares at the end of the period | 158 752 560 | 144 320 560 | 90 211 860 | 89 530 660 | 52 675 221 |
Adjusted weighted average number of shares during the period, fully diluted | 147 677 878 | 97 562 553 | 91 697 875 | 57 363 494 | - |
Adjusted weighted number of shares at the end of the period, fully diluted | 161 437 703 | 145 148 560 | 91 906 543 | 92 172 296 | - |
| | | | | |